Rate My Professor Mark Petrie

Professor Mark Petrie is Professor of Cardiology in the School of Cardiovascular and Metabolic Health at the University of Glasgow and an honorary consultant cardiologist at Glasgow Royal Infirmary. He maintains a high-volume clinical practice focused on heart failure. Prior to his academic appointment at the University of Glasgow in 2016, he worked for many years as an interventional and heart failure/transplant cardiologist. His research interests encompass diabetes and cardiovascular disease, intervention in heart failure, atrial fibrillation ablation in heart failure, subcutaneous furosemide in heart failure, devices in heart failure, revascularisation in heart failure, peripartum cardiomyopathy, inflammation in heart failure, microvascular disease in heart failure with preserved ejection fraction, obesity and heart failure, cardiac remodelling, iron in heart failure, and cardio-oncology.

Professor Petrie has held leadership roles in numerous clinical trials, including MARITIME, SYMPHONY, Subcut HF 1 and 2, STICH, STICH 3.0, REVIVED, DAPA-HF, EMPACT-MI, HERMES, CRAAFT-HF, STEP-HFpEF, REALIZE-K, EMPRESS-MI, IRONMAN, PARADISE-MI, and FINEARTS. He has chaired or served on over 40 clinical events committees for major trials such as EMPA-REG OUTCOME and DELIVER. He has authored more than 410 original publications in high-impact journals including the New England Journal of Medicine, The Lancet, JAMA, Circulation, and the Journal of the American College of Cardiology. He serves as a board member of the Heart Failure Association of the European Society of Cardiology, where he chairs its HFpEF/HFmrEF group, and as a board member of the British Society of Heart Failure. He co-chairs the Scottish Cardiac Audit Programme, chairs the Clinical Board of the Pumping Marvellous Foundation, and is Deputy Editor of the European Journal of Heart Failure.